Published in Environ Health Perspect on May 01, 2001
Alterations in TSH and Thyroid Hormones following Mobile Phone Use. Oman Med J (2009) 1.72
Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer (2004) 1.18
Nightshift work and fracture risk: the Nurses' Health Study. Osteoporos Int (2008) 0.85
Rotating nightshift work and the risk of endometriosis in premenopausal women. Am J Obstet Gynecol (2011) 0.85
Circadian Disruption and Diet-Induced Obesity Synergize to Promote Development of β-Cell Failure and Diabetes in Male Rats. Endocrinology (2015) 0.84
A cross-sectional analysis of light at night, neighborhood sociodemographics and urinary 6-sulfatoxymelatonin concentrations: implications for the conduct of health studies. Int J Health Geogr (2013) 0.83
Effects of power frequency electromagnetic fields on melatonin and sleep in the rat. Emerg Health Threats J (2012) 0.80
Stimulatory effect of morning bright light on reproductive hormones and ovulation: results of a controlled crossover trial. PLoS Clin Trials (2007) 0.77
Efficiency of cellular growth when creating small pockets of electric current along the walls of cells. Rejuvenation Res (2014) 0.76
Effect of melatonin on the induction of foci of aberrant crypts in the colon by azoxymethane in rats. Environ Health Prev Med (2004) 0.75
The melatonin hypothesis: a matter of method. Environ Health Perspect (2002) 0.75
Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer (1993) 6.24
Electric power use and breast cancer: a hypothesis. Am J Epidemiol (1987) 2.31
Profound bilateral blindness and the incidence of breast cancer. Epidemiology (1991) 1.81
Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res (1998) 1.36
Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol (1996) 1.35
Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science (1982) 1.22
The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect (1996) 1.21
Morning urinary assessment of nocturnal melatonin secretion in older women. J Pineal Res (2000) 1.09
Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. Am J Epidemiol (1992) 1.09
Geomagnetic disturbances are associated with reduced nocturnal excretion of a melatonin metabolite in humans. Neurosci Lett (1999) 1.06
Nocturnal excretion of a urinary melatonin metabolite among electric utility workers. Scand J Work Environ Health (1998) 1.01
Nocturnal exposure to intermittent 60 Hz magnetic fields alters human cardiac rhythm. Bioelectromagnetics (1998) 1.01
The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res (1999) 1.01
Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors. Cancer (1989) 0.98
6-sulphatoxymelatonin production in breast cancer patients. J Pineal Res (1990) 0.93
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol (1990) 0.92
Dose response study of human exposure to 60 Hz electric and magnetic fields. Bioelectromagnetics (1994) 0.89
A replication study of human exposure to 60-Hz fields: effects on neurobehavioral measures. Bioelectromagnetics (1992) 0.89
Alcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy women. Epidemiology (2000) 0.88
A 50-Hz electromagnetic field impairs sleep. J Sleep Res (1999) 0.87
Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers. J Pineal Res (1996) 0.87
Effects of exposure to a circularly polarized 50-Hz magnetic field on plasma and pineal melatonin levels in rats. Bioelectromagnetics (1993) 0.87
Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelectromagnetics (1996) 0.84
Human melatonin during continuous magnetic field exposure. Bioelectromagnetics (1997) 0.83
Test facility for human exposure to AC and DC magnetic fields. Bioelectromagnetics (1999) 0.82
Magnetic induction at 60 Hz in the human heart: a comparison between the in situ and isolated scenarios. Bioelectromagnetics (1999) 0.82
ELF exposure facility for human testing. Bioelectromagnetics (1992) 0.82
The validity of melatonin as an oncostatic agent. J Pineal Res (1997) 0.82
Inhibition of melatonin secretion onset by low levels of illumination. J Sleep Res (1996) 0.81
Exploring the EMF-Melatonin Connection: A Review of the Possible Effects of 50/60-Hz Electric and Magnetic Fields on Melatonin Secretion. Int J Occup Environ Health (1996) 0.80
Melatonin and adrenocorticotropic hormone levels in video display unit workers during work and leisure. J Occup Environ Med (1996) 0.80
60-Hz magnetic field exposure effects on the melatonin rhythm and photoperiod control of reproduction. Am J Physiol (1996) 0.80
Multi-night exposure to 60 Hz magnetic fields: effects on melatonin and its enzymatic metabolite. J Pineal Res (2000) 0.80
Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields. J Pineal Res (2000) 0.80
The physiology and pharmacology of melatonin in humans. Horm Res (1998) 0.79
Influence of human model resolution on computed currents induced in organs by 60-Hz magnetic fields. Bioelectromagnetics (1997) 0.79
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron (1989) 3.06
Magnetic field exposure and cardiovascular disease mortality among electric utility workers. Am J Epidemiol (1999) 1.82
Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest (1986) 1.61
Nocturnal magnetic field exposure: gender-specific effects on heart rate variability and sleep. Clin Neurophysiol (2000) 1.39
Chrysotile asbestos in the lungs of persons in New York City. Arch Environ Health (1971) 1.39
Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res (1998) 1.36
Coping in real time: using Ecological Momentary Assessment techniques to assess coping with the urge to smoke. Res Nurs Health (1998) 1.31
Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency. Pain (1980) 1.14
Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene (2007) 1.13
Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med (1980) 1.06
Nocturnal exposure to intermittent 60 Hz magnetic fields alters human cardiac rhythm. Bioelectromagnetics (1998) 1.01
Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease. Arch Intern Med (1982) 0.98
Identification of asbestos in human tissues. J Occup Med (1973) 0.97
Anaphylaxis produced by rubber glove contact. Case reports and immunological identification of the antigens involved. Clin Exp Allergy (1989) 0.91
Tetrodotoxin-sensitive and -insensitive action potentials in myotubes. J Cell Physiol (1973) 0.90
Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients. Psychooncology (1997) 0.90
Cholinergic and adrenergic receptors on mouse cardiocytes in vitro. Dev Biol (1977) 0.89
Self-report of circadian type reflects the phase of the melatonin rhythm. Biol Psychol (1999) 0.89
Dose response study of human exposure to 60 Hz electric and magnetic fields. Bioelectromagnetics (1994) 0.89
A replication study of human exposure to 60-Hz fields: effects on neurobehavioral measures. Bioelectromagnetics (1992) 0.89
Pharmacologic characterization of the Na+ ionophores in L6 myotubes. Proc Natl Acad Sci U S A (1976) 0.87
Brain frequency magnetic fields alter cardiac autonomic control mechanisms. Clin Neurophysiol (2000) 0.87
Reversal theory constructs and cigarette availability predict lapse early in smoking cessation. Res Nurs Health (1995) 0.86
Calcium-dependent glutamate cytotoxicity in a neuronal cell line. Brain Res (1988) 0.84
Bilateral adrenal neuroblastoma is different. Eur J Pediatr Surg (2007) 0.84
Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelectromagnetics (1996) 0.84
Human melatonin during continuous magnetic field exposure. Bioelectromagnetics (1997) 0.83
Angiotensin-converting enzyme activity in postmortem human tissues. Lab Invest (1983) 0.82
Cardiac autonomic control mechanisms in power-frequency magnetic fields: a multistudy analysis. Environ Health Perspect (2000) 0.82
[Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010]. An Pediatr (Barc) (2011) 0.82
Exposure to strong ELF magnetic fields does not alter cardiac autonomic control mechanisms. Bioelectromagnetics (2000) 0.82
ELF exposure facility for human testing. Bioelectromagnetics (1992) 0.82
Test facility for human exposure to AC and DC magnetic fields. Bioelectromagnetics (1999) 0.82
Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds. Am Rev Respir Dis (1987) 0.82
[Congenital neuroblastomas]. Cir Pediatr (2004) 0.81
Mycotic aneurysms of the petrous portion of the internal carotid artery. A report of 2 cases. S Afr J Surg (1983) 0.81
Glutamate cytotoxicity in a neuronal cell line is blocked by membrane depolarization. Brain Res (1988) 0.81
High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support. Groupo Español de Trasplante de Médula Osea en Niños. J Clin Oncol (2000) 0.81
Appetitive and replacement naps: EEG and behavior. Science (1977) 0.80
Multi-night exposure to 60 Hz magnetic fields: effects on melatonin and its enzymatic metabolite. J Pineal Res (2000) 0.80
Human sleep in 60 Hz magnetic fields. Bioelectromagnetics (1999) 0.80
Human exposure to 60-Hz magnetic fields: neurophysiological effects. Int J Psychophysiol (1999) 0.80
Reversal theory's mastery and sympathy states in smoking cessation. Image J Nurs Sch (1995) 0.80
The impact of mastectomy on self-concept and social function: a combined cross-sectional and longitudinal study with comparison groups. Women Health (1987) 0.80
An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis. Chest (1986) 0.80
Reversal theory and smoking: a state-based approach to ex-smokers' highly tempting situations. J Consult Clin Psychol (1990) 0.79
Effects of attention, as indexed by subsequent memory, on electrodermal detection of information. J Appl Psychol (1978) 0.79
Serum angiotensin-converting-enzyme in rabbits with and without pulmonary granulomatosis. Granulomatosis induced with complete-Freund's-adjuvant or BCG. Sarcoidosis (1986) 0.79
Standardization of the prick test. A comparative study of three methods. Allergy (1985) 0.79
Muscarinic cholinergic binding sites in the developing avian heart. Dev Biol (1977) 0.78
[Allergy to human insulin, clinical and immunologic aspects and therapeutic approach: apropos of a case]. Rev Clin Esp (1988) 0.78
Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. Aviat Space Environ Med (2001) 0.78
Meprobamate reduces accuracy of physiological detection of deception. Science (1981) 0.78
Autologous stem cell transplantation for advanced Hodgkin's disease in children. Spanish group for BMT in children (GETMON), Spain. Bone Marrow Transplant (2000) 0.78
Recombinant human erythropoietin (rh-Epo) administration to normal child bone marrow donors. Bone Marrow Transplant (1998) 0.78
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998. Bone Marrow Transplant (2005) 0.78
Reversal theory analysis of relapse crises following smoking cessation. Patient Educ Couns (1993) 0.78
[Drug-induced fever caused by pyrazolones]. Med Clin (Barc) (1984) 0.78
Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases. Bone Marrow Transplant (1998) 0.78
Modified total fasting and obesity: results of a multicentric study. Int J Obes (1982) 0.77
Smoking and EEG power spectra: effects of differences in arousal seeking. Int J Psychophysiol (1995) 0.77
Evaluation of two different oestrus-synchronisation methods with timed artificial insemination and resynchronisation of returns to oestrus in lactating Holstein cows. Anim Reprod Sci (2003) 0.77
Relation between alpha adrenergic receptor occupation and contractile response: radioligand and physiologic studies in canine aorta. J Pharmacol Exp Ther (1984) 0.77
Analysis of factors affecting PBPC collection in low-weight children with malignant disorders. Cytotherapy (2004) 0.77
Melatonin and 6-OHMS in high-intensity magnetic fields. J Pineal Res (2001) 0.76
Exercise testing in the evaluation of human responses to powerline frequency fields. Aviat Space Environ Med (1988) 0.76
All-night exposure to EMF does not alter urinary melatonin, 6-OHMS or immune measures in older men and women. J Pineal Res (2001) 0.76
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatr Hematol Oncol (2007) 0.76
Heart rate variability and physiological arousal in men exposed to 60 Hz magnetic fields. Bioelectromagnetics (2000) 0.76
Effects of methanol vapor on human neurobehavioral measures. Res Rep Health Eff Inst (1991) 0.76
Dietary treatment of lymphedema by restriction of long-chain triglycerides. Angiology (1994) 0.75
Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement. Clin Transl Oncol (2012) 0.75
Influence of apolipoprotein E polymorphism on plasma vitamin A and vitamin E levels. Eur J Clin Invest (2002) 0.75
Innervation of heart cells in culture by an endogenous source of cholinergic neurons. Proc Natl Acad Sci U S A (1976) 0.75